Obagi Medical Products Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Obagi Medical Products Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014318
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Obagi Medical Products Inc (Obagi), a subsidiary of Valeant Pharmaceuticals International Inc is a drug company that manufactures, sells, and markets skin care systems. The company provides products that include targeted solutions, tretinoin products, transformation systems, skin recovery, in-office procedures, essential products, and others. It also offers obagi professional-c serums, obagi condition and enhance systems, obagi nu-derm system, obagi blue peel, obagi blue peel radiance, and obagi rosaclear system, obagi elastiderm eye products, and others. The company’s products are used for treating fine lines, wrinkles, acne, melasma, laxity, skin shallowness, photo damage, hyper pigmentation, and others. Obagi is headquartered in Irvine, California, the US.

Obagi Medical Products Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Obagi Medical Products Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Obagi Medical Products Inc, Medical Devices Deals, 2011 to YTD 2017 9
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Obagi Medical Products Enters into Distribution Agreement with Nextcell Medical 11
Licensing Agreements 12
Sirona Biochem Enters Into Licensing Agreement With Obagi Medical For TFC-849 12
Acquisition 13
Haitong International Zhonghua Finance Acquires Obagi Medical Products from Valeant Pharma for USD190 Million 13
Valeant Pharma International Completes Acquisition Of Obagi Medical Products For US$418 Million 14
Obagi Medical Products Inc – Key Competitors 16
Obagi Medical Products Inc – Key Employees 17
Obagi Medical Products Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Key Facts 2
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Obagi Medical Products Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Obagi Medical Products Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Obagi Medical Products Inc, Medical Devices Deals, 2011 to YTD 2017 9
Obagi Medical Products Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Obagi Medical Products Enters into Distribution Agreement with Nextcell Medical 11
Sirona Biochem Enters Into Licensing Agreement With Obagi Medical For TFC-849 12
Haitong International Zhonghua Finance Acquires Obagi Medical Products from Valeant Pharma for USD190 Million 13
Valeant Pharma International Completes Acquisition Of Obagi Medical Products For US$418 Million 14
Obagi Medical Products Inc, Key Competitors 16
Obagi Medical Products Inc, Key Employees 17

★海外企業調査レポート[Obagi Medical Products Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sinocare Meditech Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sinocare Meditech Inc (Sinocare Meditech) formerly known as Freedom Meditech Inc, is a medical device company that provides ophthalmic medical devices. The company develops and commercializes ophthalmic medical devices for both chronic disease detection and the management of diabetes. It pro …
  • Baoviet Holdings
    Baoviet Holdings - Strategy, SWOT and Corporate Finance Report Summary Baoviet Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Owen Mumford Ltd:企業の戦略的SWOT分析
    Owen Mumford Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • The Star Entertainment Group Ltd:企業の戦略・SWOT・財務情報
    The Star Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary The Star Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Covalon Technologies Ltd (COV):製品パイプライン分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen …
  • Lotus Pharmaceutical Co Ltd (1795):製薬・医療:M&Aディール及び事業提携情報
    Summary Lotus Pharmaceutical Co Ltd (Lotus Pharmaceutical), a subsidiary of Alvogen Inc is a pharmaceutical company that develops and sells pharmaceutical products. The company provides products that are used in the treatment of rheumatology, cancer, cardiology, dyslipidemia, hypertension, woman hea …
  • CVS Health Corporation:企業のM&A・事業提携・投資動向
    CVS Health Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CVS Health Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Grupo Industrial Saltillo, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Grupo Industrial Saltillo, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Industrial Saltillo, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • National Australia Bank Group Ltd:戦略・SWOT・企業財務分析
    National Australia Bank Group Ltd - Strategy, SWOT and Corporate Finance Report Summary National Australia Bank Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • SM Prime Holdings, Inc.:企業の戦略・SWOT・財務情報
    SM Prime Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary SM Prime Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • North Pacific Bank,Ltd:企業の戦略・SWOT・財務情報
    North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report Summary North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MMC Corp Bhd (MMCCORP):企業の財務・戦略的SWOT分析
    Summary MMC Corp Bhd (MMC) is an investment holding company which carries out mining, mineral exploration and construction services. It operates through ports and logistics, energy and utilities, engineering and industrial development divisions. The company offers containers, bulk and breakbulk, liq …
  • Gemphire Therapeutics Inc (GEMP):企業の財務・戦略的SWOT分析
    Gemphire Therapeutics Inc (GEMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Kernel Holding SA:企業の戦略・SWOT・財務情報
    Kernel Holding SA - Strategy, SWOT and Corporate Finance Report Summary Kernel Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Beckman Research Institute Of The City Of Hope-製薬・医療分野:企業M&A・提携分析
    Summary Beckman Research Institute of The City Of Hope (Beckman Research), a subsidiary of City of Hope is a biomedical research institute that provides a range of healthcare services. The institute provides treatment that includes diabetes progression and treatment, immunology and imaging, mechanis …
  • China Telecom Corporation Limited:戦略・SWOT・企業財務分析
    China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • The Maryland Technology Development Corp:企業のM&A・事業提携・投資動向
    The Maryland Technology Development Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Maryland Technology Development Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed …
  • ERG Renew SpA-エネルギー分野:企業M&A・提携分析
    Summary ERG Renew S.p.A. (ERG Renew), formerly Entad S.p.A., a subsidiary of ERG S.p.A, is a power company that generates electricity from renewable sources. The company generates electricity mainly through wind. ERG Renew and its subsidiaries operate in Italy, France, Bulgaria/Romania, Germany, and …
  • Uscom Ltd. (UCM):医療機器:M&Aディール及び事業提携情報
    Summary Uscom Ltd. (Uscom) is a medical device company that operates in non-invasive hemodynamic market. It focuses on the development, design, manufacture and marketing of non-invasive cardiac monitoring devices. Uscom’s product portfolio includes its flagship product USCOM 1A (ultrasonic cardiac o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆